KK
TBPH

KLP Kapitalforvaltning’s Theravance Biopharma TBPH Stock Holding History

KLP Kapitalforvaltning’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Buy
41,900
+33,500
+399% +$555K ﹤0.01% 1322
2026
Q1 		$136K Buy
+8,400
New +$149K ﹤0.01% 1962
2025
Q1 		– Sell
-7,300
Closed -$68.7K – 2292
2024
Q4 		$68.7K Buy
+7,300
New +$66.4K ﹤0.01% 2195

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

KLP Kapitalforvaltning's TBPH Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Theravance Biopharma (TBPH) stake by 399% in Q2 2026, buying an estimated $555K and bringing the position to 41,900 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

KLP Kapitalforvaltning first reported a position in TBPH in Q4 2024 and has held it in 3 quarters since. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • KLP Kapitalforvaltning held 41,900 shares of Theravance Biopharma worth $712K as of Q2 2026.
  • KLP Kapitalforvaltning bought 33,500 Theravance Biopharma shares in Q2 2026, an estimated $555K.
  • Theravance Biopharma made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1322 holding.
  • KLP Kapitalforvaltning first reported a position in Theravance Biopharma in Q4 2024 and has held it in 3 quarters since.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.